Kathleen M. O’Neil

Author

Kathleen M. O’Neil

Riley Hospital for Children

Also Known As

J Olson, J. Olson, K M O'Neil, K M O’Neil, K O'Neil, K O’Neil, K. M. O'Neil, K. O'Neil, K. O’Neil, K.M. O'Neil

111

Publications

Citations

H-Index

109

Concepts

All Affiliations

Riley Hospital for Children Cincinnati Children's Hospital Medical Center Nationwide Children's Hospital Hackensack University Medical Center Boston Children's Hospital

About

Kathleen M. O’Neil is an author at Riley Hospital for Children specializing in medicine, autoimmune disease, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Arts	1	1	18
2	Education	1	1	18
3	Engineering	1	1	65
4	Health Sciences	1	1	28
5	Humanities	1	1	123

Kathleen M. O’Neil

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition Raphaela Goldbach‐Mansky, Natalie Dailey Garnes, Scott Canna, New England Journal of Medicine	2006	888
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis Carol A. Wallace, Edward H. Giannini, Steven J. Spalding, Arthritis & Rheumatism	2011	304
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation Nicolino Ruperto, Seza Özen, Angela Pistorio, Annals of the Rheumatic Diseases	2010	232
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases Adriana A. de Jesus, Yangfeng Hou, Stephen R. Brooks, Journal of Clinical Investigation Inflammatory Lung DiseaseChronic InterferonLung InflammationImmunodeficienciesImmunology	2019	227
Development of consensus treatment plans for juvenile localized scleroderma: A roadmap toward comparative effectiveness studies in juvenile localized scleroderma Suzanne C. Li, Kathryn S. Torok, Elena Pope, Arthritis Care & Research	2012	206
Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood David A. Cabral, América G. Uribe, Susanne M. Benseler, Arthritis & Rheumatism	2009	181
The Localized Scleroderma Skin Severity Index and Physician Global Assessment of Disease Activity: A Work in Progress Toward Development of Localized Scleroderma Outcome Measures Thaschawee Arkachaisri, Soamarat Vilaiyuk, Suzanne C. Li, The Journal of Rheumatology	2009	177
Randomized, Double‐Blind, Placebo‐Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis Norman T. Ilowite, Kristi Prather, Yuliya Lokhnygina, Arthritis & Rheumatology	2014	158
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study David A. Cabral, Debra Canter, Eyal Muscal, Arthritis & Rheumatology	2016	141
Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis Michiko Suzuki, Kristina Wiers, Marisa S. Klein‐Gitelman, Pediatric Nephrology InflammationGlomerulonephritisPediatric Lupus NephritisAutoimmune DiseaseSystemic Lupus Erythematosus	2008	138

Page 1